Rekah Pharmaceutical (Israel) Price History

REKA Stock  ILA 1,456  1.00  0.07%   
If you're considering investing in Rekah Stock, it is important to understand the factors that can impact its price. As of today, the current price of Rekah Pharmaceutical stands at 1,456, as last reported on the 25th of February, with the highest price reaching 1,464 and the lowest price hitting 1,456 during the day. At this point, Rekah Pharmaceutical is very steady. Rekah Pharmaceutical maintains Sharpe Ratio (i.e., Efficiency) of 0.0489, which implies the firm had a 0.0489 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Rekah Pharmaceutical, which you can use to evaluate the volatility of the company. Please check Rekah Pharmaceutical's Semi Deviation of 2.69, risk adjusted performance of 0.0448, and Coefficient Of Variation of 1958.76 to confirm if the risk estimate we provide is consistent with the expected return of 0.13%.
  
Rekah Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0489

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskREKAHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 2.62
  actual daily
23
77% of assets are more volatile

Expected Return

 0.13
  actual daily
2
98% of assets have higher returns

Risk-Adjusted Return

 0.05
  actual daily
3
97% of assets perform better
Based on monthly moving average Rekah Pharmaceutical is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Rekah Pharmaceutical by adding it to a well-diversified portfolio.

Rekah Pharmaceutical Stock Price History Chart

There are several ways to analyze Rekah Stock price data. The simplest method is using a basic Rekah candlestick price chart, which shows Rekah Pharmaceutical price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceNovember 12, 20241499.0
Lowest PriceDecember 23, 20241308.0

Rekah Pharmaceutical February 25, 2025 Stock Price Synopsis

Various analyses of Rekah Pharmaceutical's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Rekah Stock. It can be used to describe the percentage change in the price of Rekah Pharmaceutical from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Rekah Stock.
Rekah Pharmaceutical Market Facilitation Index 0.21 
Rekah Pharmaceutical Price Daily Balance Of Power 0.13 
Rekah Pharmaceutical Price Rate Of Daily Change 1.00 
Rekah Pharmaceutical Price Action Indicator(3.50)
Rekah Pharmaceutical Accumulation Distribution 0.21 

Rekah Pharmaceutical February 25, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Rekah Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Rekah Pharmaceutical intraday prices and daily technical indicators to check the level of noise trading in Rekah Stock and then apply it to test your longer-term investment strategies against Rekah.

Rekah Stock Price History Data

The price series of Rekah Pharmaceutical for the period between Wed, Nov 27, 2024 and Tue, Feb 25, 2025 has a statistical range of 191.0 with a coefficient of variation of 3.45. The price distribution for the period has arithmetic mean of 1394.55. The median price for the last 90 days is 1388.0. The company had dividends distributed to its stock-holders on 2022-04-06.
OpenHighLowCloseVolume
02/24/2025 1,456  1,464  1,456  1,456  39.00 
02/20/2025 1,498  1,498  1,455  1,455  87.00 
02/19/2025 1,475  1,479  1,456  1,479  900.00 
02/18/2025 1,487  1,498  1,480  1,486  384.00 
02/17/2025 1,483  1,483  1,463  1,463  832.00 
02/13/2025 1,460  1,484  1,460  1,484  97.00 
02/12/2025 1,478  1,482  1,457  1,457  9,838 
02/11/2025 1,428  1,479  1,428  1,479  977.00 
02/10/2025 1,442  1,478  1,408  1,454  3,299 
02/06/2025 1,440  1,456  1,413  1,413  2,369 
02/05/2025 1,441  1,441  1,419  1,441  40.00 
02/04/2025 1,426  1,426  1,410  1,426  65.00 
02/03/2025 1,458  1,486  1,352  1,352  3,773 
01/30/2025 1,399  1,400  1,344  1,344  1,293 
01/29/2025 1,381  1,382  1,342  1,342  552.00 
01/28/2025 1,360  1,390  1,360  1,363  1,669 
01/27/2025 1,450  1,450  1,327  1,327  13.00 
01/23/2025 1,369  1,403  1,369  1,382  1,195 
01/22/2025 1,360  1,372  1,352  1,352  2,172 
01/21/2025 1,343  1,394  1,343  1,394  2,204 
01/20/2025 1,408  1,430  1,340  1,365  4,527 
01/16/2025 1,389  1,389  1,387  1,387  3,318 
01/15/2025 1,369  1,377  1,369  1,377  607.00 
01/14/2025 1,399  1,399  1,325  1,376  2,684 
01/13/2025 1,392  1,395  1,362  1,388  3,928 
01/09/2025 1,368  1,380  1,352  1,352  2,774 
01/08/2025 1,382  1,383  1,337  1,337  1,493 
01/07/2025 1,387  1,389  1,333  1,333  483.00 
01/06/2025 1,350  1,360  1,350  1,360  1,213 
01/02/2025 1,398  1,398  1,398  1,398  23.00 
12/31/2024 1,369  1,369  1,305  1,330  10,725 
12/30/2024 1,364  1,364  1,316  1,320  3,449 
12/26/2024 1,330  1,350  1,330  1,340  7,912 
12/25/2024 1,371  1,380  1,350  1,364  3,645 
12/24/2024 1,315  1,380  1,301  1,332  9,946 
12/23/2024 1,346  1,399  1,306  1,308  5,146 
12/19/2024 1,394  1,394  1,349  1,349  23.00 
12/18/2024 1,400  1,401  1,400  1,400  4,285 
12/17/2024 1,394  1,395  1,394  1,395  722.00 
12/16/2024 1,391  1,391  1,391  1,391  1.00 
12/12/2024 1,400  1,400  1,388  1,400  13.00 
12/11/2024 1,382  1,410  1,354  1,400  2,585 
12/10/2024 1,392  1,392  1,382  1,392  28.00 
12/09/2024 1,369  1,401  1,368  1,401  1,599 
12/05/2024 1,380  1,380  1,373  1,380  6.00 
12/04/2024 1,377  1,389  1,347  1,378  1,440 
12/03/2024 1,396  1,397  1,370  1,370  860.00 
12/02/2024 1,373  1,400  1,366  1,366  701.00 
11/28/2024 1,439  1,499  1,439  1,499  134.00 
11/27/2024 1,389  1,431  1,389  1,389  8.00 
11/26/2024 1,489  1,489  1,422  1,422  1,206 
11/25/2024 1,438  1,438  1,422  1,438  3.00 
11/21/2024 1,431  1,431  1,373  1,373  37.00 
11/20/2024 1,404  1,447  1,384  1,384  47.00 
11/19/2024 1,465  1,465  1,405  1,405  38.00 
11/18/2024 1,443  1,443  1,373  1,373  39.00 
11/14/2024 1,475  1,475  1,400  1,401  3,239 
11/13/2024 1,481  1,481  1,481  1,481  3.00 
11/12/2024 1,499  1,499  1,481  1,499  73.00 
11/11/2024 1,456  1,471  1,435  1,435  2,029 
11/07/2024 1,437  1,450  1,382  1,382  3,757 

About Rekah Pharmaceutical Stock history

Rekah Pharmaceutical investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Rekah is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Rekah Pharmaceutical will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Rekah Pharmaceutical stock prices may prove useful in developing a viable investing in Rekah Pharmaceutical
Rekah Pharmaceutical Industry Ltd. engages in the manufacture, marketing, sale, and distribution of prescription and OTC drugs, dermo-cosmetics, vitamins, and nutritional supplements in Israel. The company was founded in 1941 and is based in Holon, Israel. REKAH PHARMA operates under Drug ManufacturersSpecialty Generic classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 9 people.

Rekah Pharmaceutical Stock Technical Analysis

Rekah Pharmaceutical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Rekah Pharmaceutical technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Rekah Pharmaceutical trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Earnings Calls Now

   

Earnings Calls

Check upcoming earnings announcements updated hourly across public exchanges
All  Next Launch Module

Rekah Pharmaceutical Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Rekah Pharmaceutical's price direction in advance. Along with the technical and fundamental analysis of Rekah Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Rekah to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Rekah Stock analysis

When running Rekah Pharmaceutical's price analysis, check to measure Rekah Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rekah Pharmaceutical is operating at the current time. Most of Rekah Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Rekah Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rekah Pharmaceutical's price. Additionally, you may evaluate how the addition of Rekah Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format